Cross-protection between distantly related spotted fever group rickettsiae

Vaccine. 2003 Sep 8;21(25-26):3901-5. doi: 10.1016/s0264-410x(03)00301-3.

Abstract

Two excellent C3H/HeN mouse models of spotted fever rickettsioses caused by the distantly related organisms, Rickettsia conorii and Rickettsia australis, were utilized to evaluate the possibility of the stimulation of broad cross-protective immunity. Sublethal infection stimulated complete immunity, that is absence of disease, after challenge with a dose of the heterologous Rickettsia that uniformly killed naïve mice. In contrast, heterologous immune sera did not protect mice against a lethal dose (two LD50) of rickettsiae in the mouse toxicity neutralization assay, the standard method for evaluation of rickettsial vaccine potency. These observations suggest that development of a broadly protective vaccine against spotted fever group (SFG) rickettsiae is feasible, and the results indicate that mouse toxicity neutralization is an inappropriate method for evaluation of candidate vaccines.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Bacterial / analysis
  • Antibodies, Bacterial / biosynthesis
  • Antibody Specificity
  • Cross Reactions
  • Diatrizoate Meglumine
  • Male
  • Mice
  • Mice, Inbred C3H
  • Neutralization Tests
  • Rickettsia conorii / immunology*
  • Rickettsia rickettsii / immunology*
  • Rickettsia rickettsii / isolation & purification
  • Rocky Mountain Spotted Fever / prevention & control*

Substances

  • Antibodies, Bacterial
  • Diatrizoate Meglumine